When: Price at $345-349

Then: Add 25% at starter sizing

When: Price at $335-340

Then: Add 25% at starter sizing

When: Price at $333.57 with MACD histogram turning positive

Then: Add 50% at full sizing

HOLD with underweight bias for new capital; maintain position with 345 stop and 320 full exit trigger; add December 340 put hedge; deploy new capital only if JPM pulls back to 330-345 zone

• JPM traded through $360 and $280 in 2025; anyone who bought at $360 had to stomach a 23% drawdown before the rally
• MACD histogram peaked at plus 3.01 on June 17 and rolled to negative after eight weeks of new highs, representing textbook negative momentum divergence
• MACD line reading of plus 7.09 reflects trending but not accelerating momentum
• Current volume on rally is roughly half of June breakout volume
• Price to book of 2.72 is at a multi-year high versus the historical decade range of 1.5-2.0 times
• ROE of 17.79 percent supports premium valuation but multiple expansion from here requires continued ROE expansion or sustained earnings beats
• In a normalization scenario, 2.0-2.5 times book is more realistic, implying 10-25% multiple derating without earnings change
• 86% no-cut odds: NIM benefits but reaccelerating inflation could break consumer credit and force provisioning higher
• JPM beta near one means no insulation from broader market de-rating on hot CPI
• Research manager verdict is HOLD with underweight bias for new capital; technical report final proposal is HOLD; macro report acknowledges constructive but qualifies with risks; fundamental report strong but flags balance sheet growth, rate sensitivity, regulatory overhang
• Three separate analytical frames independently arrived at HOLD
• Deployment target is 330-345 zone with three-to-one upside to risk asymmetry
• Aggressive analyst's recommendation to trim downside protection while adding at current levels is characterized as worst possible risk management

→ vs aggressive: Survivorship bias: JPM at $279 and $360 history shows price and risk management matter; high entries without disciplined exits produce drawdowns; the failure mode of buying at $362 with 10-15% drawdown is more painful than missing upside

→ vs aggressive: MACD misread: high absolute reading (plus 7.09) reflects trending, not accelerating; histogram crossing below zero after eight weeks of deceleration is negative momentum divergence, not cooling; this is when stops should tighten, not when to add exposure

→ vs aggressive: Volume misinterpretation: declining volume on up days at upper Bollinger band is 'diminishing buying conviction,' not healthy accumulation; confirmed breakout requires expanding volume; aggressive analyst chooses bullish interpretation of ambiguous data

→ vs aggressive: Valuation defense incomplete: premium franchises mean revert; P/B at multi-year high requires continued ROE expansion or earnings beats to sustain; 10-25% multiple derating possible in credit cycle normalization without any earnings change

→ vs aggressive: Macro not unambiguously supportive: 86% no-cut odds benefits NIM but if原因是inflation reacceleration, same environment breaks consumer credit and commercial real estate; CPI is a coin flip with non-trivial downside

→ vs aggressive: Risk management error: recommending to trim downside protection while adding at current levels is worst possible advice given bearish MACD cross, upper Bollinger band, 52-week high, and binary CPI print; should add December 340 put hedge instead

HOLD existing positions; do not add at $362; add modestly if pullback to $351-$356 with momentum resetting; keep put hedge; use $345 trailing stop; react to CPI price action rather than pre-positioning

• 2Q26 EPS of $7.70, ROE of 17.79%, NII up ~10% YoY, $44B annual capital return are best-in-class fundamentals
• Franchise dominance evidenced by Olympics partnership, Kinexys win, AI debt leadership, Klarna integration - these support the premium 2.72x P/B multiple
• MACD histogram crossed negative after peaking eight weeks ago with momentum declining from plus 3.01 to minus 0.01 - distribution in slow motion
• At upper Bollinger band at $362 near 52-week high ahead of binary CPI print - not a setup for removing tail protection
• $351-$356 represents better risk-reward tactical add zone than waiting for $330-$345 which may never trigger in grinding bull market
• MACD bearish cross at plus 7.09 not benign - eight weeks of momentum decay before new highs is how bull markets end
• December $340 put hedge is non-negotiable cheap insurance given $30B annual buyback and 1.67% dividend yield structural support
• CPI print has roughly balanced impact on JPM with slight negative convexity to hot prints given 0.98 beta - hold through print and react to price action
• Breakout above $365 on volume confirmation makes $375-$385 target viable for modest scaling; rejection at $365 confirms distribution thesis

→ vs aggressive: Trim the put hedge at $362 near upper Bollinger band with bearish MACD cross ahead of binary CPI is genuinely bad risk management - removing tail protection at the worst possible technical setup

→ vs aggressive: Survivorship bias on price entry - JPM also traded from $360 down to $280 in 2025; picking $279 as start point flatters the case while ignoring the drawdown risk at elevated entry prices

→ vs aggressive: Attributing declining volume on up days to institutional accumulation is the optimistic interpretation when the cautious read is also valid - discipline requires waiting for confirmation

→ vs conservative: Overweighting historical 1.5-2.0x book valuation ranges ignores structural change - high-teens ROE, relentless capital return, and franchise dominance may defensibly support 2.5-2.8x book

→ vs conservative: 10-25% multiple compression scenario requires credit cycle turn that 8% recession odds and 86% no-cut regime pricing do not support - describing tail risk as base case

→ vs conservative: Too passive - refusal to add at any price above $345 concedes all upside; the $330-$345 optimal entry zone is set up to never trigger in a grinding bull market